According to Twist Bioscience 's latest financial reports the company's current earnings (TTM) are -$0.2 B. In 2022 the company made an earning of -$0.22 B a decrease over its 2021 earnings that were of -$0.18 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.21 B | -4.39% |
2022 | -$0.22 B | 20.99% |
2021 | -$0.18 B | 52.28% |
2020 | -$0.12 B | -16.55% |
2019 | -$0.14 B | 84.8% |
2018 | -$75.32 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$19.09 M | -90.02% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$73.07 M | -61.80% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.53 B | 176.37% | ๐บ๐ธ USA |
Novocure
NVCR | -$0.17 B | -11.28% | Jersey |